(11-15-2021, 04:10 PM)stockguru Wrote: (11-15-2021, 03:42 PM)ken-do-nim Wrote: We use OKTA at work.
Do you own MARA? Just curious. I know you like that industry
Have you bought more RIO yet?
MARA - nope, and I don't care if it's taken off like a rocket. If I were to buy it again, it would go down sooner or later, and I wouldn't end up making money on it. Like Fenders said, I need to stay away from equities I don't have conviction in.
RIO - up to 30 shares. Still 70 more to go to reach where I was. I'm looking forward to finishing it off.
NAIL - wow it's back over 100 last I checked. I still don't think this is a triple that over time goes up like
SOXL,
TECL, and
TQQQ do. If I had any now I would surely sell, then wait for it to go back to 60 and start the wheel all over again.
LABU - my vote for worst triple.
ORC - keeps slowly sinking. That 15-16% yield tempts me no longer.
VZ, T - I got out of these, even with the small amounts I had in them
OHI, AGNC - more yield traps I won't return to
NLY - I have about $100 in it as a "watch".
TTD, NVDA, TSLA, ISRG, ADBE, GOOGL, FB, UPST - I like these tickers but I got out of individual stocks in my ROTH. I'm sure they will come back next year or the year after in the taxable.
MRNA - if it's going back up I don't want to know. All my other mistakes this year were papercuts compared to this body blow. Still, in the long run I believe in their technology and I will eventually bring it back if it is at a sane price. Ideally when they have some other drugs in phase 3 trials.
Despite all of my missteps this year, the taxable is up 43.3% year to date and the ROTH 66.11%. That said, the ROTH hasn't moved since August.